Alfa Wassermann Articles
Alfa Wassermann and Norgine get EU approval for Xifaxan
9 December 2012
Theravance in up to $63.5 million deal with Alfa Wassermann for velusetrag; RuiYi links with arGEN-X on MAb
5 October 2012
Salix and Alfa Wassermann expand rifaximin accord
10 August 2012
Showing 1-4 of 4 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
